Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel Polymeric Micelles and Adebelimab + HP in First-Line Advanced HER2+ Breast Cancer
NCT07581795Phase 2Recruiting
- Sponsor
- Fudan University
- Start
- Jul 2026
- Primary completion
- Feb 2029
- Modality
- Immune Checkpoint Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, adebrelimab in HER2-positive breast cancer, sponsored by Fudan University. Started Jul 2026; status: recruiting.
02
Drugs
Paclitaxel Micelles for Injectionadebrelimab
03
Conditions
HER2-positive breast cancer
Beyond the preview
Go deeper on NCT07581795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07581795.